Market Research Logo

Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By

Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Nuclear Medicine Market. The report analyzes the Nuclear Medicine Market By Product (Therapeutic, Diagnostic), By Diagnostics (SPECT, PET), By Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy) and By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others). The Nuclear Medicine Market has been analyzed By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, France, Germany, India, China, Japan and Brazil) for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report “Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil)”, global market is projected to display a robust growth represented by a CAGR of 10.07% during 2018 – 2023.

The indication segment of Oncological disorders has been witnessing growth at a noteworthy rate over the past few years backed by increased prevalence of cancer, presence of technical advance PET and SPECT equipment to perform treatment, rising number of nuclear centers Amongst the regions, North America accounts for the largest regional share in the global nuclear medicine market in 2018. Key factors driving the robust growth rate of North America region include well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of chronic ailment such as cardiovascular disorders, neurological disorders etc. in the region.

The report titled “Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil)” has covered and analyzed the potential of Global Nuclear Medicine and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global nuclear medicine devices market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Nuclear Medicine Market (Actual Period: 2013-2017, Forecast Period: 2018-2023

  • Global Nuclear Medicine Market – Size, Growth, Forecast
  • By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)
  • By Product Type (Diagnostic, Therapeutic)
  • By Diagnostic Type (SPECT, PET)
  • By Therapeutic Type (Alpha Emitters, Beta emitters, Brachytherapy)
Regional Markets – North America, Europe, APAC and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Nuclear Medicine Market – Size and Growth
  • By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)
  • By Product Type (Diagnostic, Therapeutic)
  • By Diagnostic Type (SPECT, PET)
  • By Therapeutic Type (Alpha Emitters, Beta emitters, Brachytherapy)
Country Analysis - U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil)
  • Nuclear Medicine Market – Size and Growth
  • By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)
Other Report Highlights
  • Market Dynamics – Drivers and Restraints
  • Market Trends
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape
  • Competitive Landscape
  • Company Analysis – Bracco Imaging, Lantheus Holding, Curium, Jubilant Lifesciences, 3B Pharmaceutical Cardinal Health Advanced Accelerator Application, Eckert & Ziegler


1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
Table A: List of Abbreviations
4. Nuclear Medicine Market Overview
Table 1: Nuclear Medicine Market Segmentation Flowchart
Table 2: Nuclear Medicine Market Segmentation Flowchart
5. Global Nuclear Medicine : Growth and Forecast
5.1 By Value (2013-2017)
Table 3: Global Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
5.2 By Value (2018-2023)
Table 4: Global Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million)
Table 5: Population ages 65 and above, By Select Region, 2013-2017 (% of total)
Table 6: Projected global population aged 60 years & above In Billions)
Table 7: Projected global population (In Billions)
Table 8: Global Health Expenditure Per Capita, (2012-2016, USD Trillion)
Table 9: Global Health Expenditure Per Capita, By Select Countries,(2016, USD)
Table C: Pipeline of Diagnostic Nuclear Medicine
Table D: Pipeline of Diagnostic Nuclear Medicine
Table E: Pipeline of Diagnostic Nuclear Medicine
Table F: Pipeline of Diagnostic Nuclear Medicine
6. Global Nuclear Medicine Market: By Indication
6.1 Global Nuclear Medicine Market-By Product Type: Breakdown(%)
6.1.1 Global Nuclear Medicine Market Size and Share, By Product Type, 2017
Table 10: Global Nuclear Medicine Market Size, By Product Type, 2017 (%)
6.1.2 Global Nuclear Medicine Market Size and Share, By Product Type, 2023
Table 11: Global Nuclear Medicine Market Size, By Product Type, 2023F (%)
6.2 Global Diagnostic Nuclear Medicine Market Overview
6.2.1 By Value (2013-2023)
Table 12: Global Diagnostic Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Table 13: Global Diagnostic Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
6.3 Global Therapeutic Nuclear Medicine Market Overview
Table G: Radionuclide Used for Diagnosis and Treatment
6.3.1 By Value (2013-2023)
Table 14: Global Therapeutic Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Table 15: Global Therapeutic Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
Table 16: Global Prevalence of Different Type of Cancer (2013-2017, Thousands)
Table H: Physical Properties of Radionuclides Used in Therapeutic Nuclear Medicine Studies
7 Global Nuclear Medicine Market: By Therapeutic Type
7.1 Global Nuclear Medicine Market: By Therapeutic Type : Breakdown(%)
7.1.1 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type , 2017
Table 17: Global Nuclear Medicine Market Size, By Therapeutic Type, 2017 (%)
7.1.2 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type ,2023
Table 18: Global Nuclear Medicine Market Size, By Diagnostic Type, 2023F (%)
7.2 Global Beta Emitters Nuclear Medicine Market Overview
7.2.1 By Value (2013-2023)
Table 19: Global Beta Emitters Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Table 20: Global Beta Emitters Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
7.3 Global Alpha Emitters Nuclear Medicine Market Overview
7.3.1 By Value (2013-2023)
Table 21: Global Alpha Emitter Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Table 22: Global Alpha Emitter Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
7.4 Global Brachytherapy Nuclear Medicine Market Overview
7.4.1 By Value (2013-2023)
Table 23: Global Brachytherapy Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Table 24: Global Brachytherapy Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
8 Global Nuclear Medicine Market :By Diagnostic Type
8.1 Global Nuclear Medicine Market :By Diagnostic Type: Breakdown(%)
8.1.1 Global Nuclear Medicine Market :By Diagnostic Type, 2017
Table 25: Global Nuclear Medicine Market Size, By Diagnostic Type, 2017 (%)
8.1.2 Global Nuclear Medicine Market :By Diagnostic Type, 2023
Table 26: Global Nuclear Medicine Market Size, By Diagnostic Type, 2023F (%)
8.2 Global SPECT Nuclear Medicine Market Overview
8.2.1 By Value (2013-2023)
Table 27: Global SPECT Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Table 28: Global SPECT Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
8.3 Global PET Nuclear Medicine Market Overview
8.3.1 By Value (2013-2023)
Table 29: Global PET Nuclear Medicine Market Size, By Value, 2013-2017(USD Million)
Table 30: Global PET Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million)
9. Global Nuclear Medicine Market :By Indication
9.1 Global Nuclear Medicine Market :By Indication: Breakdown(%)
9.1.1 Global Nuclear Medicine Market :Indication, 2017
Table 31: Global Nuclear Medicine Market Size, By Indication, 2017 (%)
9.1.2 Global Nuclear Medicine Market :Indication, 2023
Table 32: Global Nuclear Medicine Market Size, By Indication, 2023 (%)
9.2 Global Nuclear Medicine For Oncological Disorders Market
9.2.1 By Value (2013-2023)
Table 33: Global Nuclear Medicine For Oncological Disorders Market Size, By Value,2013-2017(USD Million)
Table 34: Global Nuclear Medicine For Oncological Disorders Market Size, By Value,2018E-2023F (USD Million)
Table 35: Prevalence of Cancer Per 100,000 in different Countries in 2018 ( In Thousands)
Table 36: Global Prevalence of Different Type of Cancer in year 2016 & 2017 ( In Thousands)
9.3 Global Nuclear Medicine For Cardiovascular Disorders Market
9.3.1 By Value (2013-2023)
Table 37: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2013-2017(USD Million)
Table 38: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2018E-2023F (USD Million)
Table 39: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2018E-2023F (USD Million)
Table 40: Global Prevalence of Cardiovascular Disease (2012-2016 , Million)
9.4 Global Nuclear Medicine For Neurological Disorders Market
9.4.1 By Value (2013-2023)
Table 41: Global Nuclear Medicine For Neurological Disorders Market Size, By Value,2013-2017(USD Million)
Table 42: Global Nuclear Medicine For Neurological Disorders Market Size, By Value,2018E-2023F (USD Million)
9.5 Global Nuclear Medicine For Other Disorders Market
9.5.1 By Value (2013-2023)
Table 43: Global Nuclear Medicine For Others Disorders Market Size, By Value,2013-2017(USD Million)
Table 44: Global Nuclear Medicine For Others Disorders Market Size, By Value,2013-2017(USD Million)
10. Global Nuclear Medicine Market: Regional Analysis
10.1 Global Nuclear Medicine Market, By Region: Breakdown (%)
10.1.1 Global Nuclear Medicine Market Size, By Region, 2017 (%)
Table 45: Global Nuclear Medicine Market Size, By Region, 2017 (%)
10.1.2 Global Nuclear Medicine Market Size, By Region, 2023 (%)
Table 46: Global Nuclear Medicine Market Size, By Region, 2023F (%)
10.2 North America Nuclear Medicine Market: An Analysis
10.2.1 By Value (2013-2017)
Table 47: North America Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Table 48: North America Population above 65 year in Million (2015, 2030F, 2050F)
10.2.2 By Value (2018-2023)
Table 49: North America Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million )
10.3 North America Nuclear Medicine Market: Segment Analysis
10.3.1 North America Nuclear Medicine Market: By Product Type , By Value(2013-2023)
Table 50: North America Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million)
10.3.2 North America Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023)
Table 51: North America Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)
10.3.3 North America Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023)
Table 52: North America Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million)
Table 53: North America Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million)
10.3.4 North America Nuclear Medicine Market: By Indication, By Value (2013-2023)
Table 55: Total Number of People With Cardiovascular Disorders in North America, By Type,2017 (In thousands)
Table 56: Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)
Table 57: North America Nuclear Medicine Market, Country Share, 2017 (% of Total)
Table 58: North America Nuclear Medicine , Country Share, 2023F (% of Total)
10.4 North America Nuclear Medicine Market: Country Analysis (U.S. and Canada)
10.4.1 U.S. Nuclear Medicine Market, By Value (2013-2023)
Table 59: United States Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Table 60: United States Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million)
Table 61: U.S. Per Capita Health Expenditure, 2012-2016 ( USD)
10.4.1.1 U.S. Nuclear Medicine Market, By Indication, By Value (2013-2023)
Table 62: United States Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Table 63: New Estimated Cases of Cancer in United States, By Type 2018
Table 64: New Estimated Cases of Cancer in United States (2014-2018)
Table 65: Estimated Cases of Cardiovascular Disorders in United States (2013-2017)(In Thousands)
Table 66: United States Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 67: Total Number of People With Cardiovascular Disorders in United States, By Type,2017 (In thousands)
Table 68: Total Number of People With Cardiovascular Disorders in United States, By Type,2017 (In thousands)
10.4.2 Canada Nuclear Medicine Market, By Value (2013-2023)
Table 69: Canada Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
10.4.2.1 Canada Nuclear Medicine Market, By Indication, By Value (2013-2023)
Table 70: Canada Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Table 71: Canada Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 72: Total Number of People With Cardiovascular Disorders in Canada, By Type,2017 (In thousands)
Table 73: Prevalence of Different Type of Cancer in Canada in year 2016 & 2017 ( In Hundreds)
Table 74: Cancer Fact Sheet of Canada, 2017
10.5 Europe Nuclear Medicine Market: An Analysis
10.5.1 By Value (2013-2017)
Table 75: Europe Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
10.5.2 By Value (2018-2023)
Table 76: Europe Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million )
Table 77: Number of Magnetic Resonance Imaging (MRI) Scans By Using Imaging Equipment Number, 2016, Per 100,000 Inhabitants
10.6 Europe Nuclear Medicine Market: Segment Analysis
10.6.1 Europe Nuclear Medicine Market: By Product Type , By Value(2013-2023)
Table 78: Europe Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million)
10.6.2 Europe America Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023)
Table 79: Europe Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)
10.6.3 Europe Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023)
Table 80: Europe Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million)
10.6.4 Europe Nuclear Medicine Market: By Indication, By Value (2013-2023)
Table 81: Europe Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Table 82: Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Hundreds)
Table 83: Western Europe Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 84: Total Number of People With Cardiovascular Disorders in Western Europe, By Type,2017 (In thousands)
Table 85: Europe Nuclear Medicine Market, Country Share, 2017 (% of Total)
Table 86: Europe Nuclear Medicine Market, Country Share, 2023 (% of Total)
10.7 Europe Nuclear Medicine Market: Country Analysis (Germany, France., Rest of Europe)
10.7.1 Germany Nuclear Medicine Market, By Value (2013-2023)
Table 87: Germany Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Table 88: Germany Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million)
10.7.1.1 Germany Nuclear Medicine Market, By Indication, By Value (2013-2023)
Table 89: Germany Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Table 90: Germany Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 91: Total Number of People With Cardiovascular Disorders in Germany, By Type,2017 (In thousands)
Table 92: Total Number of People With Cardiovascular Disorders in Germany, By Type,2017 (In thousands)
10.7.2 France Nuclear Medicine Market, By Value (2013-2023)
Table 93: France Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Table 94: France Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million)
10.7.2.1 France Nuclear Medicine Market, By Indication, By Value (2013-2023)
Table 95: France Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Table 96: France Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 97: Total Number of People With Cardiovascular Disorders in France, By Type,2017 (In thousands)
Table 98: Prevalence of Different Type of Cancer in France in year 2016 & 2017 ( In Hundreds)
10.7.3 Rest of Europe Nuclear Medicine Market, By Value (2013-2023)
Table 99: Rest of Europe Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Table 100: Rest of Europe Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
10.8 Asia Pacific Nuclear Medicine Market: An Analysis
10.8.1 By Value (2013-2017)
Table 101: Asia Pacific Nuclear Medicine Market Size, By Value, Forecast, 2013-2018(USD Million )
10.8.2 By Value (2018-2023)
Table 102: Asia Pacific Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million )
10.9 Asia Pacific Nuclear Medicine Market: Segment Analysis
10.9.1 Asia Pacific Nuclear Medicine Market: By Product Type , By Value(2013-2023)
Table 103: Asia Pacific Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million)
10.9.2 Asia Pacific America Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023)
Table 104: Rest of World Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)
10.9.3 Asia Pacific Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023)
Table 105: Asia Pacific Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million)
10.9.4 Asia Pacific Nuclear Medicine Market: By Indication, By Value (2013-2023)
Table 106: Asia Pacific Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Table 107: Asia Pacific Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 108: Total Number of People With Cardiovascular Disorders in Asia Pacific, By Type,2017
Table 109: Asia Pacific Nuclear Medicine Market, Country Share, 2017 (% of Total)
Table 110: Asia Pacific Nuclear Medicine, Country Share, 2023 (% of Total)
10.10 Asia Pacific Nuclear Medicine Market: Country Analysis (India, China Japan & Rest of Asia Pacific)
10.10.1 China Nuclear Medicine Market, By Value (2013-2023)
Table 111: China Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Table 112: China Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
Table 113: China Healthcare Expenditure (2012-2016, USD Billion)
Table 114: China Population 65 Years & Above (% of Total), 2012-2016
10.10.1.1 China Nuclear Medicine Market, By Indication, By Value (2013-2023)
Table 115: China Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Table 116: China Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 117: Total Number of People With Cardiovascular Disorders in China, By Type,2017 (In thousands)
Table 118: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)
10.10.2 Japan Nuclear Medicine Market, By Value (2013-2023)
Table 119: Japan Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Table 120: Japan Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
Table 121: Japan Per Capita Health Expenditure (2012-2016,USD)
Table 122: Japan Population 65 Years & Above (% of Total), 2012-2016
10.10.2.1 Japan Nuclear Medicine Market, By Indication, By Value (2013-2023)
Table 123: Japan Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Table 124: Japan Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 125: Total Number of People With Cardiovascular Disorders in Japan, By Type,2017 (In thousands)
Table 126: Prevalence of Different Type of Cancer in Japan in year 2016 & 2017 ( In Hundreds)
10.10.3 India Nuclear Medicine Market, By Value (2013-2023)
Table 127: India Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million )
Table 128: India Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
10.10.3.1 India Nuclear Medicine Market, By Indication, By Value (2013-2023)
Table 129: India Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
10.10.4 Rest of Asia Pacific Nuclear Medicine Market, By Value (2013-2023)
Table 130: Rest of Asia Pacific Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Table 131: Rest of Asia Pacific Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
10.11 Rest of World Nuclear Medicine Market: An Analysis
10.11.1 By Value (2013-2017)
Table 132: Rest of World Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
10.11.2 By Value (2018-2023)
Table 133: Rest of World Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million )
10.12 Rest of World Nuclear Medicine Market: Segment Analysis
10.12.1 Rest of World Nuclear Medicine Market: By Product Type , By Value(2013-2023)
Table 134: Rest of World Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million)
10.12.2 Rest of World Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023)
Table 135: Rest of World Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)
10.12.3 Rest of World Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023)
Table 136: Rest of World Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million)
10.12.4 Rest of World Nuclear Medicine Market: By Indication, By Value (2013-2023)
Table 137: Rest of World Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Table 138: North Africa and Middle East Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 139: Total Number of People With Cardiovascular Disorders in North Africa and Middle East , By Type,2017 (In thousands)
Table 140: Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds)
Table 141: Rest of World Nuclear Medicine Market, Country Share, 2017 (% of Total)
Table 142: Rest of World Nuclear Medicine , Country Share, 2023 (% of Total)
10.13 Rest of World Nuclear Medicine Market: Country Analysis (Brazil & Others)
10.13.1 Brazil Nuclear Medicine Market, By Value (2013-2023)
Table 143: Brazil Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Table 144: Brazil Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million
10.13.1 Brazil Nuclear Medicine Market, By Indication, By Value (2013-2023)
Table 145: Brazil Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Table 146: Brazil Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Table 147: Total Number of People With Cardiovascular Disorders in Brazil, By Type,2017 (In thousands)
Table 148: Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds)
10.13.2 Others Nuclear Medicine Market, By Value (2013-2023)
Table 149: Others Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Table 150: Others Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
11. Market Dynamics
11.1 Drivers
11.2 Challenges
12. Market Trends
13. Porter’s Five Forces Analysis –Nuclear Medicine Market
14. SWOT Analysis –Nuclear Medicine Market
15. Supply Chain Analysis Nuclear Medicine Market
16. Policy and Regulatory Landscape
17. Competitive Landscape
Table I: Physical Properties of Radionuclides Used in Therapeutic Nuclear Medicine Studies
18. Company Profiles
18.1 Eckert & Ziegler
Table 151: Eckert &Ziegler Sales, 2013-2017 (USD Million)
Table 152: Eckert &Ziegler Sales, By Business Group, 2017 (%)
18.2 Advanced Accelerator Applications
Table 153: Advanced Accelerator Applications Sales, 2014-2016 (USD Million)
Table 154: Advanced Accelerator Applications Sales, By Business Group, 2017 (%)
Table 155: Advanced Accelerator Applications Sales, By Region, 2017 (%)
18.3 Cardinal Health
Table 156: Cardinal Health Sales, 2013-2017 (USD Billion)
Table 157: Cardinal Health Sales, By Business Group, 2017 (%)
Table 158: Cardinal Health Sales, By Region, 2017 (%)
18.4 3B Pharmaceuticals
18.5 Jubilant Life Sciences
Table 159: Jubilant Life Sciences Sales, 2015FY-2018FY (USD Million)
Table 160: Jubilant Life Sciences Sales, By Business Group, 2017 (%)
Table 161: Jubilant Life Sciences Sales, By Region, 2017 (%)
18.6 Curium
18.7 Lantheus Holdings
Table 162: Lantheus Holdings Revenue ,2016-2017 (USD Million)
Table 163: Lantheus Holdings Revenue, By Product, 2017 (%)
Table 164: Lantheus Holdings Revenue , By Region, 2017 (%)
18.8 Bracco Imaging
Table 165: Bracco Imaging Revenue , By Region, 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report